Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.
Identifieur interne : 000896 ( Main/Exploration ); précédent : 000895; suivant : 000897Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.
Auteurs : Emmanuel Novy [France] ; Julien Scala-Bertola [France] ; Claire Roger [France] ; Philippe Guerci [France]Source :
- Anaesthesia, critical care & pain medicine [ 2352-5568 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Antibactériens (effets indésirables), Antibactériens (pharmacocinétique), Antibactériens (sang), Antibactériens (usage thérapeutique), Antibioprophylaxie (effets indésirables), Betacoronavirus (MeSH), Co-infection (prévention et contrôle), Confusion (induit chimiquement), Confusion (étiologie), Céfépime (effets indésirables), Céfépime (sang), Délire avec confusion (induit chimiquement), Délire avec confusion (étiologie), Femelle (MeSH), Humains (MeSH), Hypnotiques et sédatifs (usage thérapeutique), Infection croisée (prévention et contrôle), Infections à coronavirus (complications), Infections à coronavirus (thérapie), Maladie grave (thérapie), Mâle (MeSH), Pandémies (MeSH), Pneumopathie infectieuse sous ventilation assistée (prévention et contrôle), Pneumopathie virale (complications), Pneumopathie virale (thérapie), Sepsie (prévention et contrôle), Sujet âgé (MeSH), Surveillance des médicaments (MeSH), Sédation profonde (MeSH), Ventilation artificielle (effets indésirables), bêta-Lactames (effets indésirables), bêta-Lactames (pharmacocinétique), bêta-Lactames (sang), bêta-Lactames (usage thérapeutique).
- MESH :
- effets indésirables : Antibactériens, Antibioprophylaxie, Céfépime, Infections à coronavirus, Pneumopathie virale, Ventilation artificielle, bêta-Lactames.
- induit chimiquement : Confusion, Délire avec confusion.
- pharmacocinétique : Antibactériens, bêta-Lactames.
- prévention et contrôle : Co-infection, Infection croisée, Pneumopathie infectieuse sous ventilation assistée, Sepsie.
- sang : Antibactériens, Céfépime, bêta-Lactames.
- thérapie : Infections à coronavirus, Maladie grave, Pneumopathie virale.
- usage thérapeutique : Antibactériens, Hypnotiques et sédatifs, bêta-Lactames.
- étiologie : Confusion, Délire avec confusion.
- Adulte d'âge moyen, Betacoronavirus, Femelle, Humains, Mâle, Pandémies, Sujet âgé, Surveillance des médicaments, Sédation profonde.
English descriptors
- KwdEn :
- Aged (MeSH), Anti-Bacterial Agents (adverse effects), Anti-Bacterial Agents (blood), Anti-Bacterial Agents (pharmacokinetics), Anti-Bacterial Agents (therapeutic use), Antibiotic Prophylaxis (adverse effects), Betacoronavirus (MeSH), Cefepime (adverse effects), Cefepime (blood), Coinfection (prevention & control), Confusion (chemically induced), Confusion (etiology), Coronavirus Infections (complications), Coronavirus Infections (therapy), Critical Illness (therapy), Cross Infection (prevention & control), Deep Sedation (MeSH), Delirium (chemically induced), Delirium (etiology), Drug Monitoring (MeSH), Female (MeSH), Humans (MeSH), Hypnotics and Sedatives (therapeutic use), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Ventilator-Associated (prevention & control), Pneumonia, Viral (complications), Pneumonia, Viral (therapy), Respiration, Artificial (adverse effects), Sepsis (prevention & control), beta-Lactams (adverse effects), beta-Lactams (blood), beta-Lactams (pharmacokinetics), beta-Lactams (therapeutic use).
- MESH :
- chemical , adverse effects : Anti-Bacterial Agents, Cefepime, beta-Lactams.
- chemical , blood : Anti-Bacterial Agents, Cefepime, beta-Lactams.
- chemical , pharmacokinetics : Anti-Bacterial Agents, beta-Lactams.
- chemical , therapeutic use : Anti-Bacterial Agents, Hypnotics and Sedatives, beta-Lactams.
- adverse effects : Antibiotic Prophylaxis, Respiration, Artificial.
- chemically induced : Confusion, Delirium.
- complications : Coronavirus Infections, Pneumonia, Viral.
- etiology : Confusion, Delirium.
- prevention & control : Coinfection, Cross Infection, Pneumonia, Ventilator-Associated, Sepsis.
- therapy : Coronavirus Infections, Critical Illness, Pneumonia, Viral.
- Aged, Betacoronavirus, Deep Sedation, Drug Monitoring, Female, Humans, Male, Middle Aged, Pandemics.
DOI: 10.1016/j.accpm.2020.04.005
PubMed: 32315803
PubMed Central: PMC7166006
Affiliations:
- France
- Grand Est, Languedoc-Roussillon, Lorraine (région), Occitanie (région administrative)
- Nancy, Nîmes
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.</title>
<author><name sortKey="Novy, Emmanuel" sort="Novy, Emmanuel" uniqKey="Novy E" first="Emmanuel" last="Novy">Emmanuel Novy</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France. Electronic address: e.novy@chru-nancy.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Scala Bertola, Julien" sort="Scala Bertola, Julien" uniqKey="Scala Bertola J" first="Julien" last="Scala-Bertola">Julien Scala-Bertola</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Nîmes</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Guerci, Philippe" sort="Guerci, Philippe" uniqKey="Guerci P" first="Philippe" last="Guerci">Philippe Guerci</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32315803</idno>
<idno type="pmid">32315803</idno>
<idno type="doi">10.1016/j.accpm.2020.04.005</idno>
<idno type="pmc">PMC7166006</idno>
<idno type="wicri:Area/Main/Corpus">001647</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001647</idno>
<idno type="wicri:Area/Main/Curation">001647</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001647</idno>
<idno type="wicri:Area/Main/Exploration">001647</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.</title>
<author><name sortKey="Novy, Emmanuel" sort="Novy, Emmanuel" uniqKey="Novy E" first="Emmanuel" last="Novy">Emmanuel Novy</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France. Electronic address: e.novy@chru-nancy.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Scala Bertola, Julien" sort="Scala Bertola, Julien" uniqKey="Scala Bertola J" first="Julien" last="Scala-Bertola">Julien Scala-Bertola</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Languedoc-Roussillon</region>
<settlement type="city">Nîmes</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Guerci, Philippe" sort="Guerci, Philippe" uniqKey="Guerci P" first="Philippe" last="Guerci">Philippe Guerci</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy</wicri:regionArea>
<placeName><region type="region" nuts="2">Grand Est</region>
<region type="old region" nuts="2">Lorraine (région)</region>
<settlement type="city">Nancy</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Anaesthesia, critical care & pain medicine</title>
<idno type="eISSN">2352-5568</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Anti-Bacterial Agents (adverse effects)</term>
<term>Anti-Bacterial Agents (blood)</term>
<term>Anti-Bacterial Agents (pharmacokinetics)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Antibiotic Prophylaxis (adverse effects)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Cefepime (adverse effects)</term>
<term>Cefepime (blood)</term>
<term>Coinfection (prevention & control)</term>
<term>Confusion (chemically induced)</term>
<term>Confusion (etiology)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Critical Illness (therapy)</term>
<term>Cross Infection (prevention & control)</term>
<term>Deep Sedation (MeSH)</term>
<term>Delirium (chemically induced)</term>
<term>Delirium (etiology)</term>
<term>Drug Monitoring (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hypnotics and Sedatives (therapeutic use)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Ventilator-Associated (prevention & control)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Respiration, Artificial (adverse effects)</term>
<term>Sepsis (prevention & control)</term>
<term>beta-Lactams (adverse effects)</term>
<term>beta-Lactams (blood)</term>
<term>beta-Lactams (pharmacokinetics)</term>
<term>beta-Lactams (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Antibactériens (effets indésirables)</term>
<term>Antibactériens (pharmacocinétique)</term>
<term>Antibactériens (sang)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Antibioprophylaxie (effets indésirables)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Co-infection (prévention et contrôle)</term>
<term>Confusion (induit chimiquement)</term>
<term>Confusion (étiologie)</term>
<term>Céfépime (effets indésirables)</term>
<term>Céfépime (sang)</term>
<term>Délire avec confusion (induit chimiquement)</term>
<term>Délire avec confusion (étiologie)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hypnotiques et sédatifs (usage thérapeutique)</term>
<term>Infection croisée (prévention et contrôle)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (thérapie)</term>
<term>Maladie grave (thérapie)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie infectieuse sous ventilation assistée (prévention et contrôle)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (thérapie)</term>
<term>Sepsie (prévention et contrôle)</term>
<term>Sujet âgé (MeSH)</term>
<term>Surveillance des médicaments (MeSH)</term>
<term>Sédation profonde (MeSH)</term>
<term>Ventilation artificielle (effets indésirables)</term>
<term>bêta-Lactames (effets indésirables)</term>
<term>bêta-Lactames (pharmacocinétique)</term>
<term>bêta-Lactames (sang)</term>
<term>bêta-Lactames (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Cefepime</term>
<term>beta-Lactams</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Cefepime</term>
<term>beta-Lactams</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>beta-Lactams</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Hypnotics and Sedatives</term>
<term>beta-Lactams</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antibiotic Prophylaxis</term>
<term>Respiration, Artificial</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Confusion</term>
<term>Delirium</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antibactériens</term>
<term>Antibioprophylaxie</term>
<term>Céfépime</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Ventilation artificielle</term>
<term>bêta-Lactames</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Confusion</term>
<term>Delirium</term>
</keywords>
<keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Confusion</term>
<term>Délire avec confusion</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr"><term>Antibactériens</term>
<term>bêta-Lactames</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coinfection</term>
<term>Cross Infection</term>
<term>Pneumonia, Ventilator-Associated</term>
<term>Sepsis</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Co-infection</term>
<term>Infection croisée</term>
<term>Pneumopathie infectieuse sous ventilation assistée</term>
<term>Sepsie</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Antibactériens</term>
<term>Céfépime</term>
<term>bêta-Lactames</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Critical Illness</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Maladie grave</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term>
<term>Hypnotiques et sédatifs</term>
<term>bêta-Lactames</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Confusion</term>
<term>Délire avec confusion</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Betacoronavirus</term>
<term>Deep Sedation</term>
<term>Drug Monitoring</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Sujet âgé</term>
<term>Surveillance des médicaments</term>
<term>Sédation profonde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32315803</PMID>
<DateCompleted><Year>2020</Year>
<Month>07</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>08</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-5568</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>39</Volume>
<Issue>3</Issue>
<PubDate><Year>2020</Year>
<Month>06</Month>
</PubDate>
</JournalIssue>
<Title>Anaesthesia, critical care & pain medicine</Title>
<ISOAbbreviation>Anaesth Crit Care Pain Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.</ArticleTitle>
<Pagination><MedlinePgn>387-388</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S2352-5568(20)30071-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.accpm.2020.04.005</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Novy</LastName>
<ForeName>Emmanuel</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France. Electronic address: e.novy@chru-nancy.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Scala-Bertola</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of clinical pharmacology and toxicology, 54000 Nancy, France; University of Lorraine, 54000 Nancy, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Roger</LastName>
<ForeName>Claire</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of anaesthesiology and intensive care, pain and emergency medicine, Nîmes-Caremeau university hospital, 30029 Nîmes cedex 9, France; EA 2992 dysfonctions des interfaces vasculaires, university of Montpellier-Nîmes, 30908 Nîmes cedex 2, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guerci</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of anaesthesiology and intensive care medicine, university hospital of Nancy, 54511 Vandœuvre-lès-Nancy, France; University of Lorraine, 54000 Nancy, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Anaesth Crit Care Pain Med</MedlineTA>
<NlmUniqueID>101652401</NlmUniqueID>
<ISSNLinking>2352-5568</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047090">beta-Lactams</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>807PW4VQE3</RegistryNumber>
<NameOfSubstance UI="D000077723">Cefepime</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019072" MajorTopicYN="Y">Antibiotic Prophylaxis</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000077723" MajorTopicYN="N">Cefepime</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003221" MajorTopicYN="N">Confusion</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054810" MajorTopicYN="N">Deep Sedation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053717" MajorTopicYN="N">Pneumonia, Ventilator-Associated</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D047090" MajorTopicYN="N">beta-Lactams</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Therapeutic drug monitoring</Keyword>
<Keyword MajorTopicYN="Y">β lactam</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32315803</ArticleId>
<ArticleId IdType="pii">S2352-5568(20)30071-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.accpm.2020.04.005</ArticleId>
<ArticleId IdType="pmc">PMC7166006</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Grand Est</li>
<li>Languedoc-Roussillon</li>
<li>Lorraine (région)</li>
<li>Occitanie (région administrative)</li>
</region>
<settlement><li>Nancy</li>
<li>Nîmes</li>
</settlement>
</list>
<tree><country name="France"><region name="Grand Est"><name sortKey="Novy, Emmanuel" sort="Novy, Emmanuel" uniqKey="Novy E" first="Emmanuel" last="Novy">Emmanuel Novy</name>
</region>
<name sortKey="Guerci, Philippe" sort="Guerci, Philippe" uniqKey="Guerci P" first="Philippe" last="Guerci">Philippe Guerci</name>
<name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name>
<name sortKey="Scala Bertola, Julien" sort="Scala Bertola, Julien" uniqKey="Scala Bertola J" first="Julien" last="Scala-Bertola">Julien Scala-Bertola</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000896 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000896 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32315803 |texte= Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32315803" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidFranceV1
This area was generated with Dilib version V0.6.37. |